JOURNAL REPORT 2022
2019 | 2020 | 2021 | 2022

Multiple Sclerosis International

Total articles submitted to this journal each month during 2022.
Total articles published in this journal each month during 2022.
10.0

Total authors

Total unique authors of published articles in this journal during 2022.
2

Total published articles

Total articles published in this journal during 2022.
109

Days

Average time from submission to acceptance

21

Days

Average time from acceptance to publication

18

Total submitted articles

Total articles submitted to this journal during 2022.
2

Total accepted articles

Total articles accepted for publication in this journal during 2022.

Most Viewed Articles

ArticleViews
“Calcitriol” is Not Synonymous with “Vitamin D”892
Occupational therapy in the fatigue management in multiple sclerosis: an umbrella review891
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.679
Brain abnormalities in neuromyelitis optica spectrum disorder501
Spatial Analysis of Global Prevalence of Multiple Sclerosis Suggests Need for an Updated Prevalence Scale456
The therapeutic potential of the Ketogenic Diet in treating progressive multiple sclerosis412
The Effect Of Cannabis On The Clinical and Cytokine Profiles in Patients With Multiple Sclerosis372
The efficacy of functional electrical stimulation of the abdominal muscles in the treatment of chronic constipation in patients with multiple sclerosis - a pilot study372
Corpus callosum microstructural changes correlate with cognitive dysfunction in early stages of relapsing remitting multiple sclerosis: axial and radial diffusivities approach.347
Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis347

Most Viewed Special Issue Articles

ArticleViews
Evaluating the Role of Optical Coherence Tomography in Optic Neuritis401
SERUM METABOLIC PROFILE IN MULTIPLE SCLEROSIS PATIENTS332
DTI measurements in Multiple Sclerosis: evaluation of brain damage and clinical implications307
Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials240
Iron and neurodegeneration in multiple sclerosis230
Hyperacute Corticosteroid Treatment of Optic Neuritis at the Onset of Pain may prevent Visual Loss: A Case Series170
Consensus guidelines for CSF and blood biobanking for CNS biomarker studies153
Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge133
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis118
OPTICAL COHERENCE TOMOGRAPHY IN MULTIPLE SCLEROSIS AND NEUROMYELITIS OPTICA: AN UPDATE114

Key Indexes